Development of a HiBiT-tagged reporter hepatitis E virus and its utility as an antiviral drug screening platform.

Nagashima, Shigeo; Primadharsini, Putu Prathiwi; Nishiyama, Takashi; Takahashi, Masaharu; Murata, Kazumoto; Okamoto, Hiroaki

Nagashima, Shigeo; Primadharsini, Putu Prathiwi; Nishiyama, Takashi; Takahashi, Masaharu; Murata, Kazumoto; Okamoto, Hiroaki.

Afiliación

Nagashima S; Division of Virology, Department of Infection and Immunity, Jichi Medical University School of Medicine , Tochigi, Japan.
Primadharsini PP; Division of Virology, Department of Infection and Immunity, Jichi Medical University School of Medicine , Tochigi, Japan.
Nishiyama T; Division of Virology, Department of Infection and Immunity, Jichi Medical University School of Medicine , Tochigi, Japan.
Takahashi M; Division of Virology, Department of Infection and Immunity, Jichi Medical University School of Medicine , Tochigi, Japan.
Murata K; Division of Virology, Department of Infection and Immunity, Jichi Medical University School of Medicine , Tochigi, Japan.
Okamoto H; Division of Virology, Department of Infection and Immunity, Jichi Medical University School of Medicine , Tochigi, Japan.

J Virol ; 97(9): e0050823, 2023 Sep 28.

Article en En | MEDLINE | ID: mdl-37681960

Palabras clave

HiBiT tag; ORF2 capsid protein; bioluminescent protein; drug screening; hepatitis E virus; reporter virus; virus release

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Screening_studies Idioma: En Revista: J Virol Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google